The Extracellular Signal-Regulated Kinase Pathway Phosphorylates AML1, an Acute Myeloid Leukemia Gene Product, and Potentially Regulates Its Transactivation Ability

REFERENCES

• Adams, P. D., and P. J. Parker. 1992. Activation of mitogen-activated protein (MAP) kinase by a MAP kinase-kinase. J. Biol. Chem. 267:13135–13137.
   PubMedGoogle Scholar
• Alberola, I. J., K. A. Forbush, R. Seger, E. G. Krebs, and R. M. Perlmutter. 1995. Selective requirement for MAP kinase activation in thymocyte differentiation. Nature (London) 373:620–623.
   PubMedGoogle Scholar
• Alessandrini, A., C. M. Crews, and R. L. Erikson. 1992. Phorbol ester stimulates a protein-tyrosine/threonine kinase that phosphorylates and activates the Erk-1 gene product. Proc. Natl. Acad. Sci. USA 89:8200–8204.
   PubMedGoogle Scholar
• Bae, S. C., E. Ogawa, M. Maruyama, H. Oka, M. Satake, K. Shigesada, N. A. Jenkins, D. J. Gilbert, N. G. Copeland, and Y. Ito. 1994. PEBP2αB/ mouse AML1 consists of multiple isoforms that possess differential trans-activation potentials. Mol. Cell. Biol. 14:3242–3452.
   PubMed Web of Science ®Google Scholar
• Bae, S. C., E. Takahashi, Y. W. Zhang, E. Ogawa, K. Shigesada, Y. Namba, M. Sataka, and Y. Ito. 1995. Cloning, mapping and expression of PEBP2αC, a third gene encoding the mammalian Runt domain. Gene 159:245–248.
   PubMed Web of Science ®Google Scholar
• Bae, S. C., I. Y. Yamaguchi, E. Ogawa, M. Maruyama, M. Inuzuka, H. Kagoshima, K. Shigesada, M. Satake, and Y. Ito. 1993. Isolation of PEBP2αB cDNA representing the mouse homolog of human acute myeloid leukemia gene, AML1. Oncogene 8:809–814.
   PubMed Web of Science ®Google Scholar
• Bernstein, L. R., D. K. Ferris, N. H. Colburn, and M. E. Sobel. 1994. A family of mitogen-activated protein kinase-related proteins interacts in vivo with activator protein-1 transcription factor. J. Biol. Chem. 269:9401–9404.
   PubMed Web of Science ®Google Scholar
• Boyle, W. J., P. van der Geer, and T. Hunter. 1991. Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates. Methods Enzymol. 201:110–149.
   PubMed Web of Science ®Google Scholar
• Chen, L. F., K. Ito, Y. Murakami, and Y. Ito. 1995. Stimulation of polyomavirus DNA replication by a transcription factor PEBP2, abstr. 441, p. 161. In Abstracts of the 54th Annual Meeting of the Japanese Cancer Association 1995. Japanese Cancer Association, Tokyo.
   Google Scholar
• Chen, R. H., C. Abate, and J. Blenis. 1993. Phosphorylation of the c-Fos transrepression domain by mitogen-activated protein kinase and 90-kDa ribosomal S6 kinase. Proc. Natl. Acad. Sci. USA 90:10952–10956.
   PubMed Web of Science ®Google Scholar
• Chen, R. H., C. Sarnecki, and J. Blenis. 1992. Nuclear localization and regulation of erk- and rsk-encoded protein kinases. Mol. Cell. Biol. 12:915–927.
   PubMed Web of Science ®Google Scholar
• Cheng, J. T., M. H. Cobb, and R. Baer. 1993. Phosphorylation of the TAL1 oncoprotein by the extracellular-signal-regulated protein kinase ERK1. Mol. Cell. Biol. 13:801–808.
   PubMed Web of Science ®Google Scholar
• Cowley, S., H. Paterson, P. Kemp, and C. J. Marshall. 1994. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH3T3 cells. Cell 77:841–852.
   PubMed Web of Science ®Google Scholar
• Crossley, M., and S. H. Orkin. 1994. Phosphorylation of the erythroid transcription factor GATA-1. J. Biol. Chem. 269:16589–16596.
   PubMed Web of Science ®Google Scholar
• Daga, A., J. E. Tighe, and F. Calabi. 1992. Leukaemia/Drosophila homology. Nature (London) 356:484.
   PubMed Web of Science ®Google Scholar
• Davis, R. J. 1993. The mitogen-activated protein kinase signal transduction pathway. J. Biol. Chem. 268:14553–14556.
   PubMed Web of Science ®Google Scholar
• Derijard, B., M. Hibi, I. H. Wu, T. Barrett, B. Su, T. Deng, M. Karin, and R. J. Davis. 1994. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76:1025–1037.
   PubMed Web of Science ®Google Scholar
• Derijard, B., J. Raingeaud, T. Barrett, I. H. Wu, J. Han, R. J. Ulevitch, and R. J. Davis. 1995. Independent human MAP kinase signal transduction pathways defined by MEK and MKK isoforms. Science 267:682–685.
   PubMed Web of Science ®Google Scholar
• Erickson, P., J. Gao, K. S. Chang, T. Look, E. Whisenant, S. Raimondi, R. Lasher, J. Trujillo, J. Rowley, and H. Drabkin. 1992. Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt. Blood 80:1825–1831.
   PubMed Web of Science ®Google Scholar
• Erickson, P., M. Robinson, G. Owens, and H. A. Drabkin. 1994. The ETO portion of acute myeloid leukemia t(8;21) fusion transcript encodes a highly evolutionarily conserved, putative transcription factor. Cancer Res. 54:1782–1786.
   PubMed Web of Science ®Google Scholar
• Frank, R., J. Zhang, H. Uchida, S. Meyers, S. W. Hiebert, and S. D. Nimer. 1995. The AML1/ETO fusion protein blocks transactivation of the GM-CSF promoter by AML1B. Oncogene 11:2667–274.
   PubMed Web of Science ®Google Scholar
• Furukawa, K., Y. Yamaguchi, E. Ogawa, K. Shigesada, M. Satake, and Y. Ito. 1990. Aubiquitous repressor interacting with an F9 cell-specific silencer and its functional suppression by differentiated cell-specific positive factors. Cell Growth Differ. 1:135–147.
   PubMedGoogle Scholar
• Giese, K., C. Kingsley, J. R. Kirshner, and R. Grosschedl. 1995. Assembly and function of a TCRα enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions. Genes Dev. 9:995–1008.
   PubMed Web of Science ®Google Scholar
• Golub, T. R., G. F. Barker, S. K. Bohlander, S. W. Hiebert, D. C. Ward, W. P. Bray, E. Morgan, S. C. Raimondi, J. D. Rowley, and D. G. Gilliland. 1995. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proc. Natl. Acad. Sci. USA 92:4917–4921.
   PubMed Web of Science ®Google Scholar
• Gonzalez, F. A., A. Seth, D. L. Raden, D. S. Bowman, F. S. Fay, and R. J. Davis. 1993. Serum-induced translocation of mitogen-activated protein kinase to the cell surface ruffling membrane and the nucleus. J. Cell. Biol. 122:1089–1101.
   PubMedGoogle Scholar
• Gupta, S., and R. J. Davis. 1994. MAP kinase binds to the NH2-terminal activation domain of c-Myc. FEBS Lett. 353:281–285.
   PubMedGoogle Scholar
• Harlow, E., and D. Lane. 1988. Antibodies: a laboratory manual, p. 421–510. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
   Google Scholar
• Hattori, S., M. Fukuda, T. Yamashita, S. Nakamura, Y. Gotoh, and E. Nishida. 1992. Activation of mitogen-activated protein kinase and its activator by ras in intact cells and in a cell-free system. J. Biol. Chem. 267:20346–20351.
   PubMedGoogle Scholar
• Hernandez, M. C., and M. S. Krangel. 1994. Regulation of the T-cell receptor δ enhancer by functional cooperation between c-Myb and core-binding factors. Mol. Cell. Biol. 14:473–483.
   PubMedGoogle Scholar
• Hernandez, M. C., and M. S. Krangel. 1995. c-Myb and core-binding factor/ PEBP2 display functional synergy but bind independently to adjacent sites in the T-cell receptor δ enhancer. Mol. Cell. Biol. 15:3090–3099.
   PubMedGoogle Scholar
• Hill, C. S., and R. Treisman. 1995. Transcriptional regulation by extracellular signals: mechanisms and specificity. Cell 80:199–211.
   PubMed Web of Science ®Google Scholar
• Hunter, T., and M. Karin. 1992. The regulation of transcription by phosphorylation. Cell 70:375–387.
   PubMed Web of Science ®Google Scholar
• Kagoshima, H., K. Shigesada, M. Satake, Y. Ito, H. Miyoshi, M. Ohki, M. Pepling, and P. Gergen. 1993. The Runt domain identifies a new family of heteromeric transcriptional regulators. Trends Genet. 9:338–341.
   PubMedGoogle Scholar
• Kallunki, T., B. Su, I. Tsigelny, H. K. Sluss, B. Derijard, G. Moore, R. Davis, and M. Karin. 1994. JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation. Genes Dev. 8:2996–3007.
   PubMed Web of Science ®Google Scholar
• Karin, M. 1995. The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270:16483–16486.
   PubMed Web of Science ®Google Scholar
• Khalil, R. A., C. B. Menice, C. L. Wang, and K. G. Morgan. 1995. Phosphotyrosine-dependent targeting of mitogen-activated protein kinase in differentiated contractile vascular cells. Circ. Res. 76:1101–1108.
   PubMedGoogle Scholar
• Kharbanda, S., A. Saleem, Y. Emoto, R. Stone, U. Rapp, and D. Kufe. 1994. Activation of Raf-1 and mitogen-activated protein kinase during monocytic differentiation of human myeloid leukemia cells. J. Biol. Chem. 269:872–878.
   PubMed Web of Science ®Google Scholar
• Kinoshita, T., T. Yokota, K. Arai, and A. Miyajima. 1995. Suppression of apoptotic death in hematopoietic cells by signalling through the IL-3/GM-CSF receptors. EMBO J. 14:266–275.
   PubMed Web of Science ®Google Scholar
• Kolodziej, P. A., and R. A. Young. 1991. Epitope tagging and protein surveillance. Methods Enzymol. 194:508–519.
   PubMed Web of Science ®Google Scholar
• Kunkel, T. A., J. D. Roberts, and R. A. Zakour. 1987. Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol. 154:367–382.
   PubMed Web of Science ®Google Scholar
• Kurokawa, M., S. Ogawa, T. Tanaka, K. Mitani, Y. Yazaki, O. N. Witte, and H. Hirai. 1995. The AML1/Evi-1 fusion protein in the t(3;21) translocation exhibits transforming activity on Rat1 fibroblasts with dependence on Evi-1 sequence. Oncogene 11:833–840.
   PubMedGoogle Scholar
• Kurokawa, M., T. Tanaka, K. Tanaka, S. Ogawa, K. Mitani, Y. Yazaki, and H. Hirai. 1996. Overexpression of the AML1 proto-oncoprotein in NIH3T3 cells leads to neoplastic transformation depending on the DNA-binding and transactivational potencies. Oncogene 12:883–892.
   PubMed Web of Science ®Google Scholar
• LaBonne, C., B. Burke, and M. Whitman. 1995. Role of MAP kinase in mesoderm induction and axial patterning during Xenopus development. Development 121:1475–1486.
   PubMedGoogle Scholar
• Lenormand, P., C. Sardet, G. Pages, G. L’Allemain, A. Brunet, and J. Pouyssegur. 1993. Growth factors induce nuclear translocation of MAP kinases (p42mapk and p44mapk) but not of their activator MAP kinase kinase (p45mapkk) in fibroblasts. J. Cell Biol. 122:1079–1088.
   PubMed Web of Science ®Google Scholar
• Levanon, D., V. Negreanu, Y. Bernstein, A. I. Bar, L. Avivi, and Y. Groner. 1994. AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization. Genomics 23:425–432.
   PubMed Web of Science ®Google Scholar
• Liu, P., S. A. Tarle, A. Hajra, D. F. Claxton, P. Marlton, M. Freedman, M. J. Siciliano, and F. S. Collins. 1993. Fusion between transcription factor CBFβ/PEBP2β and a myosin heavy chain in acute myeloid leukemia. Science 261:1041–1044.
   PubMed Web of Science ®Google Scholar
• Liu, P. P., A. Hajra, C. Wijmenga, and F. S. Collins. 1995. Molecular pathogenesis of the chromosome 16 inversion in the M4Eo. Blood 85:2289–2302.
   PubMed Web of Science ®Google Scholar
• Lu, J., M. Maruyama, M. Satake, S. C. Bae, E. Ogawa, H. Kagoshima, K. Shigesada, and Y. Ito. 1995. Subcellular localization of the α and β subunits of the acute myeloid leukemia-linked transcription factor PEBP2/CBF. Mol. Cell. Biol. 15:1651–1661.
   PubMed Web of Science ®Google Scholar
• Marshall, C. J. 1995. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80:179–185.
   PubMed Web of Science ®Google Scholar
• Meyers, S., J. R. Downing, and S. W. Hiebert. 1993. Identification of AML-1 and the (8;21) translocation protein (AML-1/ETO) as sequence-specific DNA-binding proteins: the runt homology domain is required for DNA binding and protein-protein interactions. Mol. Cell. Biol. 13:6336–6345.
   PubMed Web of Science ®Google Scholar
• Meyers, S., N. Lenny, and S. W. Hiebert. 1995. The t(8;21) fusion protein interferes with AML-1B-dependent transcriptional activation. Mol. Cell. Biol. 15:1974–1982.
   PubMed Web of Science ®Google Scholar
• Minden, A., A. Lin, M. McMahon, C. Lange-Carter, B. Derijard, R. J. Davis, G. L. Johnson, and M. Karin. 1994. Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. Science 266:1719–1723.
   PubMed Web of Science ®Google Scholar
• Mitani, K., S. Ogawa, T. Tanaka, H. Miyoshi, M. Kurokawa, H. Mano, Y. Yazaki, M. Ohki, and H. Hirai. 1994. Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia. EMBO J. 13:504–510.
   PubMed Web of Science ®Google Scholar
• Miyoshi, H., T. Kozu, K. Shimizu, K. Enomoto, N. Maseki, Y. Kaneko, N. Kamada, and M. Ohki. 1993. The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript. EMBO J. 12:2715–2721.
   PubMed Web of Science ®Google Scholar
• Miyoshi, H., M. Ohira, K. Shimizu, K. Mitani, H. Hirai, T. Imai, K. Yokoyama, E. Soeda, and M. Ohki. 1995. Alternative splicing and genomic structure of the AML1 gene involved in acute myeloid leukemia. Nucleic Acids Res. 23:2762–2769.
   PubMed Web of Science ®Google Scholar
• Miyoshi, H., K. Shimizu, T. Kozu, N. Maseki, Y. Kaneko, and M. Ohki. 1991. t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc. Natl. Acad. Sci. USA 88:10431–10434.
   PubMed Web of Science ®Google Scholar
• Muller, A. J., J. C. Young, A. M. Pendergast, M. Pondel, N. R. Landau, D. R. Littman, and O. N. Witte. 1991. BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias. Mol. Cell. Biol. 11:1785–1792.
   PubMed Web of Science ®Google Scholar
• Nuchprayoon, I., S. Meyers, L. M. Scott, J. Suzow, S. Hiebert, and A. D. Friedman. 1994. PEBP2/CBF, the murine homolog of the human myeloid AML1 and PEBP2p/CBFp proto-oncoproteins, regulates the murine myeloperoxidase and neutrophil elastase genes in immature myeloid cells. Mol. Cell. Biol. 14:5558–5568.
   PubMed Web of Science ®Google Scholar
• Nucifora, G., C. R. Begy, P. Erickson, H. A. Drabkin, and J. D. Rowley. 1993. The 3;21 translocation in myelodysplasia results in a fusion transcript between the AML1 gene and the gene for EAP, a highly conserved protein associated with the Epstein-Barr virus small RNA EBER 1. Proc. Natl. Acad. Sci. USA 90:7784–7788.
   PubMed Web of Science ®Google Scholar
• Nucifora, G., C. R. Begy, H. Kobayashi, D. Roulston, D. Claxton, B. J. Pedersen, E. Parganas, J. N. Ihle, and J. D. Rowley. 1994. Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3;21)(q26;q22) translocations. Proc. Natl. Acad. Sci. USA 91:4004–4008.
   PubMed Web of Science ®Google Scholar
• Nucifora, G., D. J. Birn, R. Espinosa III, P. Erickson, M. M. LeBeau, D. Roulston, T. W. McKeithan, H. Drabkin, and J. D. Rowley. 1993. Involvement of the AML1 gene in the t(3;21) in therapy-related leukemia and in chronic myeloid leukemia in blast crisis. Blood 81:2728–2734.
   PubMed Web of Science ®Google Scholar
• Nucifora, G., and J. D. Rowley. 1995. AML1 and the 8;21 and 3;21 trans-locations in acute and chronic myeloid leukemia. Blood 86:1–14.
   PubMed Web of Science ®Google Scholar
• Ogawa, E., M. Inuzuka, M. Maruyama, M. Satake, F. M. Naito, Y. Ito, and K. Shigesada. 1993. Molecular cloning and characterization of PEBP2p, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2a. Virology 194:314–331.
   PubMed Web of Science ®Google Scholar
• Ogawa, E., M. Maruyama, L. F. Chen, Y. Murakami, and Y. Ito. 1995. Analysis of the mechanism of transcription activation by PEBP2, abstr. 713, p. 230. In Abstracts of the 54th Annual Meeting of the Japanese Cancer Association 1995. Japanese Cancer Association, Tokyo.
   Google Scholar
• Ogawa, E., M. Maruyama, H. Kagoshima, M. Inuzuka, J. Lu, M. Satake, K. Shigesada, and Y. Ito. 1993. PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene. Proc. Natl. Acad. Sci. USA 90:6859–6863.
   PubMed Web of Science ®Google Scholar
• Ohki, M. 1993. Molecular basis of the t(8;21) translocation in acute myeloid leukaemia. Semin. Cancer Biol. 4:369–375.
   PubMed Web of Science ®Google Scholar
• Okazaki, K., and N. Sagata. 1995. The Mos/MAP kinase pathway stabilizes c-Fos by phosphorylation and augments its transforming activity in NIH3T3 cells. EMBO J. 14:5048–5059.
   PubMed Web of Science ®Google Scholar
• Okazaki, K., and N. Sagata. 1995. MAP kinase activation is essential for oncogenic transformation of NIH3T3 cells by Mos. Oncogene 10:1149–1157.
   PubMedGoogle Scholar
• Okuda, K., J. S. Sanghera, S. L. Pelech, Y. Kanakura, M. Hallek, J. D. Griffin, and B. J. Druker. 1992. Granulocyte-macrophage colony-stimulating factor, interleukin-3, and steel factor induce rapid tyrosine phosphorylation of p42 and p44 MAP kinase. Blood 79:2880–2887.
   PubMed Web of Science ®Google Scholar
• Okuda, T., J. Deursen, S. W. Hiebert, G. Grosbeld, and J. R. Downing. 1996. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84:321–330.
   PubMed Web of Science ®Google Scholar
• Pages, G., P. Lenormand, G. L’Allemain, J. C. Chambard, S. Meloche, and J. Pouyssegur. 1993. Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation. Proc. Natl. Acad. Sci. USA 90:8319–8323.
   PubMed Web of Science ®Google Scholar
• Pulverer, B. J., J. M. Kyriakis, J. Avruch, E. Nikolakaki, and J. R. Woodgett. 1991. Phosphorylation of c-jun mediated by MAP kinases. Nature (London) 353:670–674.
   PubMed Web of Science ®Google Scholar
• Rabault, B., and J. Ghysdael. 1994. Calcium-induced phosphorylation of ETS1 inhibits its specific DNA binding activity. J. Biol. Chem. 269:28143–18151.
   PubMed Web of Science ®Google Scholar
• Raingeaud, J., A. J. Whitmarsh, T. Barrett, B. Derijard, and R. J. Davis. 1996. MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol. Cell. Biol. 16:1247–1255.
   PubMed Web of Science ®Google Scholar
• Rao, V. N., and E. S. Reddy. 1994. Elk-1 proteins interact with MAP kinases. Oncogene 9:1855–1860.
   PubMedGoogle Scholar
• Robbins, D. J., E. Zhen, H. Owaki, C. A. Vanderbilt, D. Ebert, T. D. Geppert, and M. H. Cobb. 1993. Regulation and properties of extracellular signal-regulated protein kinases 1 and 2 in vitro. J. Biol. Chem. 268:5097–5106.
   PubMed Web of Science ®Google Scholar
• Romana, S. P., M. Mauchauffe, C. M. Le, I. Chumakov, P. D. Le, R. Berger, and O. A. Bernard. 1995. The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion. Blood 85:3662–3670.
   PubMed Web of Science ®Google Scholar
• Rudnicki, M. A., and M. W. McBurney. 1987. Cell culture methods and induction of differentiation of embryonal carcinoma cell lines, p. 19–49. In E. J. Robertson (ed.), Teratocarcinomas and embryonic stem cells. IRL Press, Oxford.
   Google Scholar
• Rutberg, S. E., L. R. Dolan, and Z. Ronai. 1994. PEBP2—a modulator of polyoma DNA replication. DNA Cell Biol. 13:865–874.
   PubMedGoogle Scholar
• Sakakura, C., I. Y. Yamaguchi, M. Satake, S. C. Bae, A. Takahashi, E. Ogawa, A. Hagiwara, T. Takahashi, A. Murakami, K. Makino, T. Nakagawa, N. Kamada and Y. Ito. 1994. Growth inhibition and induction of differentiation of t(8;21) acute myeloid leukemia cells by the DNA-binding domain of PEBP2 and the AML1/MTG8(ETO)-specific antisense oligonucleotide. Proc. Natl. Acad. Sci. USA 91:11723–11727.
   PubMed Web of Science ®Google Scholar
• Satake, M., S. Nomura, I. Y. Yamaguchi, Y. Takahama, Y. Hashimoto, M. Niki, Y. Kitamura, and Y. Ito. 1995. Expression of the Runt domainencoding PEBP2α genes in T cells during thymic development. Mol. Cell. Biol. 15:1662–1670.
   PubMed Web of Science ®Google Scholar
• Sato, N., K. Sakamaki, N. Terada, K. Arai, and A. Miyajima. 1993. Signal transduction by the high-affinity GM-CSF receptor: two distinct cytoplasmic regions ofthe common β subunit responsible for different signaling. EMBO J. 12:4181–4189.
   PubMed Web of Science ®Google Scholar
• Shirakabe, K., Y. Gotoh, and E. Nishida. 1992. Amitogen-activated protein (MAP) kinase activating factor in mammalian mitogen-stimulated cells is homologous to Xenopus M phase MAP kinase activator. J. Biol. Chem. 267:16685–16690.
   PubMedGoogle Scholar
• Sun, W., B. J. Graves, and N. A. Speck. 1995. Transactivation of the Moloney murine leukemia virus and T-cell receptor p-chain enhancers by Cbf and Ets requires intact binding sites for both proteins. J. Virol. 69:4941–4949.
   PubMed Web of Science ®Google Scholar
• Takahashi, A., M. Satake, I. Y. Yamaguchi, S. C. Bae, J. Lu, M. Maruyama, Y. W. Zhang, H. Oka, N. Arai, K. Arai, and Y. Ito. 1995. Positive and negative regulation of granulocyte-macrophage colony-stimulating factor promoter activity by AML1-related transcription factor, PEBP2. Blood 86:607–616.
   PubMed Web of Science ®Google Scholar
• Tanaka, K., T. Tanaka, S. Ogawa, M. Kurokawa, K. Mitani, Y. Yazaki, and H. Hirai. 1995. Increased expression ofAML1 during retinoic-acid-induced differentiation of U937 cells. Biochem. Biophys. Res. Commun. 211:1023–1030.
   PubMedGoogle Scholar
• Tanaka, T., K. Mitani, M. Kurokawa, S. Ogawa, K. Tanaka, J. Nishida, Y. Yazaki, Y. Shibata, and H. Hirai. 1995. Dual functions of the AML1/Evi-1 chimeric protein in the mechanism of leukemogenesis in t(3;21) leukemias. Mol. Cell. Biol. 15:2383–2392.
   PubMed Web of Science ®Google Scholar
• Tanaka, T., J. Nishida, K. Mitani, S. Ogawa, Y. Yazaki, and H. Hirai. 1994. Evi-1 raises AP-1 activity and stimulates c-fos promoter transactivation with dependence on the second zinc finger domain. J. Biol. Chem. 269:24020–24026.
   PubMedGoogle Scholar
• Tanaka, T., K. Tanaka, M. Kurokawa, and H. Hirai. Unpublished data.
   Google Scholar
• Tanaka, T., K. Tanaka, S. Ogawa, M. Kurokawa, K. Mitani, J. Nishida, Y. Shibata, Y. Yazaki, and H. Hirai. 1995. An acute myeloid leukemia gene, AML1, regulates hematopoietic myeloid cell differentiation and transcriptional activation antagonistically by two alternative spliced forms. EMBO J. 14:341–350.
   PubMed Web of Science ®Google Scholar
• Tobe, K., T. Kadowaki, H. Tamemoto, K. Ueki, K. Hara, O. Koshio, K. Momomura, Y. Gotoh, E. Nishida, Y. Akanuma, Y. Yazaki, and M. Kasuga. 1991. Insulin and 12-O-tetradecanoylphorbol-13-acetate activation of two immunologically distinct myelin basic protein/microtubule-associated protein 2 (MBP/MAP2) kinases via de novo phosphorylation of threonine and tyrosine residues. J. Biol. Chem. 266:24793–24803.
   PubMedGoogle Scholar
• Towatari, M., G. E. May, R. Marais, G. R. Perkins, C. J. Marshall, S. Cowley, and T. Enver. 1995. Regulation of GATA-2 phosphorylation by mitogen-activated protein kinase and interleukin-3. J. Biol. Chem. 270:4101–4107.
   PubMedGoogle Scholar
• Ueki, K., S. Matsuda, K. Tobe, Y. Gotoh, H. Tamemoto, M. Yachi, Y. Akanuma, Y. Yazaki, E. Nishida, and T. Kadowaki. 1994. Feedback regulation of mitogen-activated protein kinase kinase kinase activity of c-Raf-1 by insulin and phorbol ester stimulation. J. Biol. Chem. 269:15756–15761.
   PubMedGoogle Scholar
• Wang, S., Q. Wang, B. E. Crute, I. N. Melnikova, S. R. Keller, and N. A. Speck. 1993. Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor. Mol. Cell. Biol. 13:3324–3339.
   PubMed Web of Science ®Google Scholar
• Wang, S. W., and N. A. Speck. 1992. Purification of core-binding factor, a protein that binds the conserved core site in murine leukemia virus enhancers. Mol. Cell. Biol. 12:89–102.
   PubMedGoogle Scholar
• Wijmenga, C., N. A. Speck, N. C. Dracopoli, M. H. Hofker, P. Liu, and F. S. Collins. 1995. Identification of a new murine runt domain-containing gene, Cbfa3. Genomics 26:611–614.
   PubMedGoogle Scholar
• Wotton, D., J. Ghysdael, S. Wang, N. A. Speck, and M. J. Owen. 1994. Cooperative binding of Ets-1 and core binding factor to DNA. Mol. Cell. Biol. 14:840–850.
   PubMed Web of Science ®Google Scholar
• Zaiman, A. L., A. F. Lewis, B. E. Crute, N. A. Speck, and J. Lenz. 1995. Transcriptional activity of core binding factor α (AML1) and β subunits on murine leukemia virus enhancer cores. J. Virol. 69:2898–2906.
   PubMedGoogle Scholar
• Zhang, D. E., K. Fujioka, C. J. Hetherington, L. H. Shapiro, H. M. Chen, A. T. Look, and D. G. Tenen. 1994. Identification of a region which directs the monocytic activity of the colony-stimulating factor 1 (macrophage colony-stimulating factor) receptor promoter and binds PEBP2/CBF (AML1). Mol. Cell. Biol. 14:8085–8095.
   PubMed Web of Science ®Google Scholar
• Zhang, D. E., C. J. Hetherington, S. Meyers, K. L. Rhoades, C. J. Larson, H. M. Chen, S. W. Hiebert, and D. G. Tenen. 1996. CCAAT enhancerbinding protein (C/EBP) and AML1 (CBFα2) synergistically activate the macrophage colony-stimulating factor receptor promoter. Mol. Cell. Biol. 16:1231–1240.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., S. Moreland, and R. S. Moreland. 1994. Regulation of vascular smooth muscle contraction: myosin light chain phosphorylation dependent and independent pathways. Can. J. Physiol. Pharmacol. 72:1386–1391.
   PubMed Web of Science ®Google Scholar
• Zhu, X., J. E. Yeadon, and S. J. Burden. 1994. AML1 is expressed in skeletal muscle and is regulated by innervation. Mol. Cell. Biol. 14:8051–8057.
   PubMed Web of Science ®Google Scholar